WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007016319) DOMINANT NEGATIVE MUTANT KRP PROTEIN PROTECTION OF ACTIVE CYCLIN-CDK COMPLEX INHIBITION BY WILD-TYPE KRP
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/016319    International Application No.:    PCT/US2006/029349
Publication Date: 08.02.2007 International Filing Date: 28.07.2006
IPC:
A01H 1/00 (2006.01), A01H 5/00 (2006.01), C12N 15/82 (2006.01)
Applicants: TARGETED GROWTH, INC. [US/US]; 2815 Eastlake Avenue East, Suite 300, Seattle, WA 98102 (US) (For All Designated States Except US).
OLIVIER, Paul [US/US]; (US) (For US Only).
DEROCHER, Jay [US/US]; (US) (For US Only)
Inventors: OLIVIER, Paul; (US).
DEROCHER, Jay; (US)
Agent: POOR, Brian W.; Townsend And Townsend And Crew Llp, Two Embarcadero Center, 8th Floor, San Francisco, CA 94111 (US)
Priority Data:
60/703,999 29.07.2005 US
Title (EN) DOMINANT NEGATIVE MUTANT KRP PROTEIN PROTECTION OF ACTIVE CYCLIN-CDK COMPLEX INHIBITION BY WILD-TYPE KRP
(FR) PROTECTION DE PROTEINES KRP MUTANTES NEGATIVES DOMINANTES D'INHIBITION ACTIVE DU COMPLEXE CYCLINE/CDK PAR KRP DE TYPE SAUVAGE
Abstract: front page image
(EN)Disclosed are mutant CDK inhibitor (CKI) polypeptides having dominant negative antagonist activity against wild-type CKI proteins, as well as related compositions, including nucleic acids and vectors encoding the mutant CKI polypeptides and transformed host cells and transgenic plants comprising such nucleic acids and vectors. Also disclosed are related methods for using the mutant proteins to modulate cell division in cells, particularly plant cells
(FR)La présente invention a trait à des polypeptides inhibiteurs de CDK (CKI) mutants présentant une activité antagoniste négative dominante contre des protéines CKI de type sauvage, ainsi qu'à des compositions associées. Ces polypeptides comprennent des acides nucléiques et des vecteurs codant pour les polypeptides CKI mutants et des cellules hôtes transformées et des végétaux transgéniques comportant de tels acides nucléiques et vecteurs. L'invention a également trait à des procédés pour l'utilisation des protéines mutantes pour la modulation de la division cellulaire dans des cellules, notamment des cellules végétales.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)